Company intelligence / Profile preview

Jiangxi Durenhe Pharmaceutical

Zhangshu, Jiangxi, China

Ownership: Private
Development stage: Other

Overview

Jiangxi Durenhe Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a core subsidiary of the Renhe Group. The company specializes in the research, development, and large-scale manufacturing of both Traditional Chinese Medicine (TCM) and chemical drug formulations. Its product portfolio primarily focuses on over-the-counter (OTC) medications for respiratory health, pediatrics, and digestive ailments. Operating out of Jiangxi Province, the company maintains modern production facilities that comply with Good Manufacturing Practice (GMP) standards to support the broader Renhe brand's commercial reach across China.

Therapeutic areas: ImmunologyOtherInfectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Jiangxi Durenhe Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangxi Durenhe Pharmaceutical.

Explore the full profile